Print This Issue

Douglas Fraker, Deputy Director Abramson Cancer Center
December 11, 2007, Volume 54, No. 15



Dr. Douglas L. Fraker, has been named to the newly-created position of Deputy Director, Clinical Services & Programs, at the Abramson Cancer Center of the University of Pennsylvania. Dr. Fraker assumed his new role December 1, 2007. Dr. Fraker serves as the senior advisor to the Center’s Director and Health System’s senior leadership on issues concerning clinical services and associated programmatic initiatives.

“In his new position, Dr. Fraker will bring his years of clinical and administrative experience to lead the ongoing development of the Cancer Center’s integrated program initiatives of excellence for respective organ sites,” said Dr. Craig B. Thompson, director of the Abramson Cancer Center. “He’s just the right person to further enhance our mission of delivering a wide array of cancer services in an integrated program based approach.” In addition, Dr. Fraker will provide leadership on strengthening integrated clinical program initiatives as they relate to the development of robust clinical research and quality initiatives, to include tumor registry and quality assurance initiatives on cancer.

Dr. Fraker received his medical degree at Harvard Medical School and came to the University of Pennsylvania School of Medicine in 1995 as the Jonathan E. Rhoads Associate Professor of Surgery.  Prior to joining the department of surgery and the Abramson Cancer Center at the University of Pennsylvania School of Medicine, Dr. Fraker was a senior investigator and head of endocrine surgery at the National Institutes of Health, in Bethesda, Maryland. He is currently vice chairman for clinical affairs and chief, division of endocrine & oncologic surgery in the department of surgery at the School of Medicine. Dr. Fraker’s research efforts have focused on regional perfusion to treat melanoma and soft tissue sarcomas of the extremities and metastatic tumors of the liver. His clinical practice in surgery includes melanoma, sarcoma, liver tumors, and endocrine surgery of the thyroid, parathyroid, adrenal glands and pancreas.



Almanac - December 11, 2007, Volume 54, No. 15